Protein and Peptide Therapeutics

Innbundet / 2025 / Engelsk

Produktdetaljer

ISBN
9780443235306
Publisert
2025-03-01
Utgiver
Vendor
Academic Press Inc
Høyde
229 mm
Bredde
152 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
300

Volume editor
Teplow David B.

Biographical note

David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Co-Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.

Protein and Peptide Therapeutics

Innbundet / 2025 / Engelsk
Innbundet / 2025 / Engelsk
Nettpris:
2.006,-
Laveste pris siste 30 dager: 1.921,-
Kommer i salg {date}
Klikk og hent
Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
Les mer
Preface David Teplow 1. Targeting Myc with protein drugs Jumi Shin 2. Peptide-Based Inhibitors of Epigenetic Proteins Jasmin Mecinovic and Jordi Hintzen 3. TBA Charles Chen 4. Peptide Pharmacology: Pioneering Interventions for Alcohol Use Disorder Abilash Valsala Gopalakrishnan, Ramkumar Katturajan and Sabina Evan Prince 5. Peptides on Patrol: Carrier Systems for Targeted Delivery Vivek P. Chavda 6. Daptomycin: Mechanism of Action, Mechanisms of Resistance, Synthesis and Structure-activity Relationships Scott Taylor and Ryan Moreira 7. Delivery of Protein Therapeutics and Vaccines Using their Multivalent Complexes with Synthetic Polyelectrolytes Alexander K. Andrianov 8. Delivery of Therapeutic Proteins to Ocular Tissues: Barriers, Approaches, Regulatory Considerations and Future Perspectives Divyesh Harshadkumar Shastri 9. TBA Gopal Singh Bisht 10. Peptidomimetics Design and Characterization: Bridging Experimental and Computer-Based Approaches Daniele Di Marino, ALICE ROMAGNOLI and Domenico Raimondo 11. Vaccines Reimagined: The Peptide Revolution in Disease Prevention Vivek P. Chavda 12. Surface Modified Proteins and Peptides: A new arm of targeted drug delivery Vivek P. Chavda 13. Oral Delivery of Protein and Peptide Vivek P. Chavda and Pankti Balar
Les mer
Presents the latest updates in the field of protein and peptide therapeutics
Provides the latest information on protein and peptide therapeutics research Offers outstanding and original reviews on a range of protein and peptide therapeutics research topics Serves as an indispensable reference for researchers and students alike Presents the latest release in the Progress in Molecular Biology and Translational Science series
Les mer

Relaterte produkter

Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors.
Les mer
Preface David Teplow 1. Targeting Myc with protein drugs Jumi Shin 2. Peptide-Based Inhibitors of Epigenetic Proteins Jasmin Mecinovic and Jordi Hintzen 3. TBA Charles Chen 4. Peptide Pharmacology: Pioneering Interventions for Alcohol Use Disorder Abilash Valsala Gopalakrishnan, Ramkumar Katturajan and Sabina Evan Prince 5. Peptides on Patrol: Carrier Systems for Targeted Delivery Vivek P. Chavda 6. Daptomycin: Mechanism of Action, Mechanisms of Resistance, Synthesis and Structure-activity Relationships Scott Taylor and Ryan Moreira 7. Delivery of Protein Therapeutics and Vaccines Using their Multivalent Complexes with Synthetic Polyelectrolytes Alexander K. Andrianov 8. Delivery of Therapeutic Proteins to Ocular Tissues: Barriers, Approaches, Regulatory Considerations and Future Perspectives Divyesh Harshadkumar Shastri 9. TBA Gopal Singh Bisht 10. Peptidomimetics Design and Characterization: Bridging Experimental and Computer-Based Approaches Daniele Di Marino, ALICE ROMAGNOLI and Domenico Raimondo 11. Vaccines Reimagined: The Peptide Revolution in Disease Prevention Vivek P. Chavda 12. Surface Modified Proteins and Peptides: A new arm of targeted drug delivery Vivek P. Chavda 13. Oral Delivery of Protein and Peptide Vivek P. Chavda and Pankti Balar
Les mer
Presents the latest updates in the field of protein and peptide therapeutics
Provides the latest information on protein and peptide therapeutics research Offers outstanding and original reviews on a range of protein and peptide therapeutics research topics Serves as an indispensable reference for researchers and students alike Presents the latest release in the Progress in Molecular Biology and Translational Science series
Les mer

Produktdetaljer

ISBN
9780443235306
Publisert
2025-03-01
Utgiver
Vendor
Academic Press Inc
Høyde
229 mm
Bredde
152 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
300

Volume editor
Teplow David B.

Biographical note

David B. Teplow, Ph.D., is a Professor of Neurology, Emeritus, at UCLA and an internationally recognized leader in efforts to understand and treat Alzheimer's disease. Dr. Teplow's group has used a multi-disciplinary approach to determine how neurotoxic peptides, such as the amyloid β-protein (Alzheimer's disease) and α-synuclein (Parkinson’s disease), form neurotoxic structures that kill neurons and to develop the means to block these processes. Dr. Teplow received undergraduate training at UC Berkeley; a Ph.D. from the University of Washington; and was a postdoctoral scholar at Caltech. Before coming to UCLA, Dr. Teplow was a faculty member in the Department of Neurology, Harvard Medical School. Dr. Teplow has published >250 peer-reviewed articles, books and book chapters, and commentaries, in addition to serving on numerous national and international scientific advisory boards. Dr. Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology, He is Co-Editor-in-Chief of the Elsevier serial Progress in Molecular Biology and Translational Science and is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease.

Relaterte produkter